Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DUVELISIB vs ECALLANTIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DUVELISIB vs ECALLANTIDE: Safety Overview

Metric DUVELISIB ECALLANTIDE
Total FAERS Reports 757 1,206
Deaths Reported 165 23
Death Rate 21.8% 1.9%
Hospitalizations 282 499
Average Patient Age 64.7 yrs 42.9 yrs
% Female Patients 40.0% 84.1%
FDA Approval Date Sep 24, 2018 N/A
Manufacturer Secura Bio, Inc Takeda Pharmaceuticals America, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription